Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Minerals International (CMP) Asset Writedowns and Impairment (2016 - 2025)

Compass Minerals International (CMP) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $700000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $700000.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $53.7 million, a 71.88% decrease, with the full-year FY2025 number at $53.7 million, down 71.88% from a year prior.
  • Asset Writedowns and Impairment was $700000.0 for Q2 2025 at Compass Minerals International, down from $53.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $253.1 million in Q1 2021 to a low of -$23.1 million in Q3 2022.
  • A 5-year average of $71.9 million and a median of $35.3 million in 2024 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 100.67% in 2022, then crashed 46.25% in 2025.
  • Compass Minerals International's Asset Writedowns and Impairment stood at $8.4 million in 2021, then tumbled by 375.0% to -$23.1 million in 2022, then surged by 423.81% to $74.8 million in 2023, then crashed by 76.47% to $17.6 million in 2024, then plummeted by 96.02% to $700000.0 in 2025.
  • Per Business Quant, the three most recent readings for CMP's Asset Writedowns and Impairment are $700000.0 (Q2 2025), $53.0 million (Q1 2025), and $17.6 million (Q3 2024).